Newton, MA, United States of America

Ivan Yanachkov

This inventor holds 4 USPTO granted patents. Top assignees: Drug Innovation & Design, Inc., Paratek Pharmaceuticals, Inc.. Active years: 2000-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ivan Yanachkov. Retrieved from https://idiyas.com/inventor/ivan-yanachkov-0wlxcpx3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2000-2008

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Ivan Yanachkov

Introduction

Ivan Yanachkov is a notable inventor based in Newton, MA, who has made significant contributions to the field of pharmaceuticals. With a total of 4 patents to his name, he has focused on developing innovative compounds that have the potential to improve medical treatments.

Latest Patents

Among his latest patents are the "Amino-methyl substituted tetracycline compounds," which discuss pharmaceutical compositions and methods of use. Another significant patent is for "Acyclovir diester derivatives," which discloses novel prodrugs represented by a specific structural formula. These inventions highlight his commitment to advancing pharmaceutical science.

Career Highlights

Throughout his career, Ivan has worked with reputable companies such as Drug Innovation & Design, Inc. and Paratek Pharmaceuticals, Inc. His work in these organizations has allowed him to contribute to the development of groundbreaking pharmaceutical solutions.

Collaborations

Ivan has collaborated with talented individuals in his field, including Arnold Glazier and Milka Yanachkova. These partnerships have fostered a creative environment that has led to innovative discoveries.

Conclusion

Ivan Yanachkov's contributions to pharmaceutical innovation through his patents and collaborations demonstrate his dedication to improving healthcare solutions. His work continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…